The Chinese MOFCOM conditionally clears a merger in the market of eye-care antibiotic products and of contact lens care products (Novartis / Alcon)

I. Key Facts of the Case Novartis International AG, in Hünenberg, Switzerland, the world’s sixth largest pharmaceutical company, has a center in Shanghai established in 2006, besides two other R&D centers worldwide, in Switzerland and the Unites States. Alcon, as the world’s second largest manufacturer of consumer vision care products, founded in 1945 in Fort Worth, Texas, has invested in China since 1990 and has become the largest company in the sector of contact lens care products in China. The majority owned by Novartis AG as of August 25, 2010, develops, manufactures, and distributes hundreds of eye care products in more than 180 countries. CIBA VISION Corporation was established in 1980 as a diversification effort of Ciba-Geigy’s USA Pharmaceutical Division headquartered in

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • University Paris-Panthéon-Assas

Quotation

Yan Bai, The Chinese MOFCOM conditionally clears a merger in the market of eye-care antibiotic products and of contact lens care products (Novartis / Alcon), 13 August 2010, e-Competitions August 2010, Art. N° 35302

Visites 1077

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues